var data={"title":"Treatment protocols for germ cell tumors","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Treatment protocols for germ cell tumors</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-germ-cell-tumors/contributors\" class=\"contributor contributor_credentials\">Tim Brenner, PharmD, BCOP</a></dd><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-germ-cell-tumors/contributors\" class=\"contributor contributor_credentials\">Shrina Duggal, PharmD, BCOP</a></dd><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-germ-cell-tumors/contributors\" class=\"contributor contributor_credentials\">Jim Natale, PharmD, BCOP</a></dd><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-germ-cell-tumors/contributors\" class=\"contributor contributor_credentials\">Scott M Wirth, PharmD, BCOP</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-germ-cell-tumors/contributors\" class=\"contributor contributor_credentials\">John W Mucenski, PharmD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-germ-cell-tumors/contributors\" class=\"contributor contributor_credentials\">Michael E Ross, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/treatment-protocols-for-germ-cell-tumors/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Sep 13, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H14151835\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The following material represents a subset of chemotherapy regimens that are used for the treatment of patients with advanced germ cell tumors. <strong>This is</strong> <strong>not an exhaustive list</strong>; it includes regimens that are considered by the authors and editors to be commonly used and important for the care of both male and female patients with germ cell tumors. Additional regimens may be added over time, particularly as treatment evolves.</p><p>This topic review is intended to provide only a listing of chemotherapy regimens. It does not address the appropriate context for use of these regimens in the care of patients with germ cell tumors. Clinicians should refer to the individual disease-oriented topic reviews that discuss the use of these protocols in appropriate clinical situations:</p><p><ul class=\"bulletCompact-block\"><li>(See <a href=\"topic.htm?path=overview-of-the-treatment-of-testicular-germ-cell-tumors\" class=\"medical medical_review\">&quot;Overview of the treatment of testicular germ cell tumors&quot;</a>.)</li><li>(See <a href=\"topic.htm?path=extragonadal-germ-cell-tumors-involving-the-mediastinum-and-retroperitoneum\" class=\"medical medical_review\">&quot;Extragonadal germ cell tumors involving the mediastinum and retroperitoneum&quot;</a>.)</li><li>(See <a href=\"topic.htm?path=initial-risk-stratified-treatment-for-advanced-testicular-germ-cell-tumors\" class=\"medical medical_review\">&quot;Initial risk-stratified treatment for advanced testicular germ cell tumors&quot;</a>.)</li><li>(See <a href=\"topic.htm?path=treatment-of-malignant-germ-cell-tumors-of-the-ovary\" class=\"medical medical_review\">&quot;Treatment of malignant germ cell tumors of the ovary&quot;</a>.)</li></ul></p><p>These tables are provided as examples of how to administer these regimens; there may be other acceptable methods. All chemotherapy regimens must be administered by clinicians who are trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.</p><p class=\"headingAnchor\" id=\"H14152224\"><span class=\"h2\">Regimens</span></p><p class=\"headingAnchor\" id=\"H14152280\"><span class=\"h3\">Regimens for advanced germ cell tumors</span></p><p class=\"headingAnchor\" id=\"H937144214\"><span class=\"h4\">BEP (bleomycin plus etoposide and cisplatin)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>(<a href=\"image.htm?imageKey=ONC%2F65516\" class=\"graphic graphic_table graphicRef65516 \">table 1</a>)</p><p class=\"headingAnchor\" id=\"H937144239\"><span class=\"h4\">EP (etoposide plus cisplatin)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>(<a href=\"image.htm?imageKey=ONC%2F63222\" class=\"graphic graphic_table graphicRef63222 \">table 2</a>)</p><p class=\"headingAnchor\" id=\"H937144264\"><span class=\"h4\">VIP (etoposide plus ifosfamide and cisplatin)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>(<a href=\"image.htm?imageKey=ONC%2F51451\" class=\"graphic graphic_table graphicRef51451 \">table 3</a>)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"topicVersionRevision\">Topic 85695 Version 9.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li><a href=\"#H14151835\" id=\"outline-link-H14151835\">INTRODUCTION</a><ul><li><a href=\"#H14152224\" id=\"outline-link-H14152224\">Regimens</a><ul><li><a href=\"#H14152280\" id=\"outline-link-H14152280\">- Regimens for advanced germ cell tumors</a><ul><li><a href=\"#H937144214\" id=\"outline-link-H937144214\">BEP (bleomycin plus etoposide and cisplatin)</a></li><li><a href=\"#H937144239\" id=\"outline-link-H937144239\">EP (etoposide plus cisplatin)</a></li><li><a href=\"#H937144264\" id=\"outline-link-H937144264\">VIP (etoposide plus ifosfamide and cisplatin)</a></li></ul></li></ul></li></ul></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ONC/85695|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ONC/65516\" class=\"graphic graphic_table\">- Bleomycin etoposide and cisplatin regimen</a></li><li><a href=\"image.htm?imageKey=ONC/63222\" class=\"graphic graphic_table\">- Cisplatin and etoposide for relapsed germ cell tumors</a></li><li><a href=\"image.htm?imageKey=ONC/51451\" class=\"graphic graphic_table\">- VIP germ cell tumors</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=extragonadal-germ-cell-tumors-involving-the-mediastinum-and-retroperitoneum\" class=\"medical medical_review\">Extragonadal germ cell tumors involving the mediastinum and retroperitoneum</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=initial-risk-stratified-treatment-for-advanced-testicular-germ-cell-tumors\" class=\"medical medical_review\">Initial risk-stratified treatment for advanced testicular germ cell tumors</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-treatment-of-testicular-germ-cell-tumors\" class=\"medical medical_review\">Overview of the treatment of testicular germ cell tumors</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-malignant-germ-cell-tumors-of-the-ovary\" class=\"medical medical_review\">Treatment of malignant germ cell tumors of the ovary</a></li></ul></div></div>","javascript":null}